Description
This practice tool is for Medicines and Therapeutics Advisory Committees to guide the safe and effective use of sodium-glucose co-transporter 2 (SGLT2) inhibitors and medicines with glucagon-like peptide-1 receptor agonist (GLP-1RA) activity in the perioperative period
Medicines with GLP-1RA activity include both GLP-1 analogues and dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists.
The tool promotes effective communication around the management of these medicines at transitions of care and recommends provision of a comprehensive discharge medicines plan.